|
Jun 30
|
U.S. Supreme Court Asks for Views of Solicitor General in Durnell Case
|
|
Jun 27
|
Biopesticides Industry Research and Forecast Report 2021-2031 with Competitive Analysis of Corteva, Syngenta, BASF, Bayer, Koppert Biological Systems, and Certis Biologicals
|
|
Jun 25
|
KRYS Up 4% on Initiating Dosing in Rare Eye Disease Phase III Study
|
|
Jun 25
|
Amarin Soars 27% on Vazkepa Licensing Deal With Recordati in the EU
|
|
Jun 25
|
EY US & Bayer Win “Artificial Intelligence for Good” Award in 2025 AI Breakthrough Awards Program
|
|
Jun 24
|
CHMP Backs NVO's Ozempic EU Label Update for Cardiovascular Indication
|
|
Jun 23
|
Exelixis Surges On Positive Results For Next-Gen Colon Cancer Drug
|
|
Jun 13
|
Are Medical Stocks Lagging Amneal Pharmaceuticals (AMRX) This Year?
|
|
May 24
|
Trump Trade: Trump considers 50% tariff on EU, 25% on iPhones
|
|
May 23
|
Bayer Gets CHMP Nod for Eylea 8 mg in the EU for 2 Major Eye Diseases
|
|
May 23
|
Bayer’s Eylea set for longer treatment intervals to challenge Roche’s Vabysmo
|
|
May 23
|
OTC Markets Group Welcomes Bayer AG to OTCQX
|
|
May 21
|
Bayer Begins Phase I Study on BAY 3670549 in Atrial Fibrillation
|
|
May 20
|
Bayer reports FDA approved Jivi for use in pediatric patients 7 years and older
|
|
May 19
|
The Zacks Analyst Blog Highlights Bayer, Novo Nordisk, GSK, Merck and AbbVie
|
|
Apr 24
|
North Dakota enacts nation's first law shielding Roundup's maker from some cancer lawsuits
|
|
Apr 23
|
World Bank adds Bayer, Hyatt and other CEOs to private sector initiative
|
|
Apr 23
|
ConcertAI and Bayer to boost precision oncology with AI and ML insights
|
|
Feb 13
|
BridgeBio price target raised to $49 from $48 at Scotiabank
|
|
Jan 3
|
Bayer Secures End of Roundup Weedkiller Litigation in Australia
|